• Proceedings of the Korean Society of Precision Engineering Conference
• /
• 2011.06a
• /
• pp.1533-1534
• /
• 2011

• Applied Chemistry for Engineering
• /
• v.29 no.3
• /
• pp.303-306
• /
• 2018

Methyl 4-formylbenzoate (MFB), a by-product of the DMT production process, which has been disposed, was used as a starting material for the synthesis of six new fluorescent whitening agent's candidates with 4,4'-di((E)-styryl)-1,1'-biphenyl skeleton attached with an aromatic ester, the same as that of the commercial product family. All candidates were synthesized by the reaction of MFB, and its derivatives with tetraethyl biphenyl-4,4'-diylbis(methylene)diphosphonate using Wittig-Horner reaction. UV spectra for all candidates were recorded and the data were used for calculating the molar absorptivity in order to confirm the usability as a fluorescent whitening agent. All of them showed overall molar extinction coefficients (log ${\varepsilon}$ 4.59~5.00) similar to those of conventional commercial products (log ${\varepsilon}$ 4.85). In particular, compounds 16 and 17 having a dimethoxyphenyl group exhibited a molar extinction coefficient superior to those of conventional commercial products, and thus a field testing for commercialization will be conducted.

• Journal of Preventive Medicine and Public Health
• /
• v.37 no.4
• /
• pp.329-336
• /
• 2004

Objectives : Iron (Fe) is an essential element in biological processes; however excessive Fe is harmful to human health. Some air pollutants contain a high level of Fe, and the human lung could therefore be over-exposed to Fe through inhaled air pollutants. This study was performed to investigate the role of metal transporters (divalent metal transporter 1, DMT1, and metal transporter protein 1, MTP1) in the lung under the environments of Fe deficiency in the body and Fe over-exposure in the lung. Methods : Rats were fed Fe deficient (FeD, 2-6 mg Fe/kg) or Fe supplemented (FeS, 120 mg Fe/kg) diet for 4 weeks, followed by a single intratracheal instillation of ferrous sulfate at low (10 mg/kg) or high (20 mg/kg) dose. Fe concentration was analyzed in the serum, lung and liver, and histopathological findings were observed in the lung at 24 hours after Fe administration. The level of DMT1 and MTP1 expression in the lung was analyzed by RT-PCR. Also, the effect of Fe deficiency in the body was evaluated on the level of Fe concentration and metal transporters compared to FeS-diet fed rats at the end of 4-week FeD or FeS diet. Results : The 4-week FeD diet in rats induced an Fe deficiency anemia with decreased serum total Fe, increased unsaturated Fe binding capacity and hypochromic microcytic red blood cells. The concentration of Fe in the lung and liver was lower in the FeD-diet fed rats than in the FeS-diet fed rats. The level of metal transporters mRNA expression was higher in the FeD-diet fed rats than in the FeS-diet. The concentration of Fe in the lung was increased in a dose-dependent pattern after intratracheal instillation of Fe into the rats, while the level of Fe in the serum and liver was not increased in the low-dose Fe administered rats. Therefore, DMT1 and MTP1 mRNA was highly expressed in both FeD-diet and FeS-diet fed rats, after intratracheal instillation of Fe. Conclusions : DMT1 and MTP1 mRNA were more highly expressed in FeD-diet fed rats than in FeS-diet fed rats. The over-exposure of Fe intratracheally induced high expression of metal transporters and increased Fe deposition in the lung in both FeD-diet and FeS-diet fed rats, but did not increase the Fe level of the serum and liver in low-dose Fe administered rats. These results suggest that the role of metal transporters in the lung might be different in a part from the duodenum under the environment of over-exposure to Fe.

• Proceedings of the Korean Society of Precision Engineering Conference
• /
• 2013.05a
• /
• pp.1011-1012
• /
• 2013

• Applied Chemistry for Engineering
• /
• v.28 no.3
• /
• pp.294-298
• /
• 2017

Six new fluorescent whitening agent's candidates with 4,4'-di((E)-styryl)-1,1'-biphenyl skeleton which is the same as that of Uvitex FP family were synthesized using methyl 4-formylbenzoate (MFB) as a starting material. MFB has been disposed as a by-product of dimethyl terephthalate (DMT) production process. Six candidates were synthesized by the reaction of MFB, and its derivatives with tetraethyl biphenyl-4,4'-diylbis(methylene)diphosphonate (3) using Wittig-Horner reaction. A series of UV spectra were recorded and the results were used for estimating molar absorptivities of each candidates in order to find their potential application as fluorescent whitening agents. Considering the molar absorptivity (log ${\varepsilon}$ 3.95~2.60) for all candidates was lower than that of the commercial Uvitex FP 127 (log ${\varepsilon}$ 4.85), it was concluded that they are not suitable for fluorescent whitening agent applications.

• Journal of Korean Ophthalmic Optics Society
• /
• v.6 no.1
• /
• pp.119-124
• /
• 2001

Dimethyl terephthalate (DMT). 1.4-butanediol (1.4-BD) and poly (tetramethylene ether) glycol (PTMG) in the molecular weight of 2000 (g/mol) were used to synthesize poly(ether-b-ester) thermoplastic elastomers (TPEEs). The final copolymers were annealed to improve thermal stability at elevated temperatures and mechanical properties. This study showed that as the proportion of soft segment increases melting temperature and degree of crystallinity of TPEEs decrease constantly. In case of mechanical properties like flexural strength and flexural elastic modulus. $35-PTMG^{2000}$ indicates the highest values due to more efficient physical interlock.

• The Korean Journal of Physiology and Pharmacology
• /
• v.18 no.6
• /
• pp.447-456
• /
• 2014

Until now, a disease-modifying therapy (DMT) that has an ability to slow or arrest Alzheimer's disease (AD) progression has not been developed, and all clinical trials involving AD patients enrolled by clinical assessment alone also have not been successful. Given the growing consensus that the DMT is likely to require treatment initiation well before full-blown dementia emerges, the early detection of AD will provide opportunities to successfully identify new drugs that slow the course of AD pathology. Recent advances in early detection of AD and prediction of progression of the disease using various biomarkers, including cerebrospinal fluid (CSF) $A{\beta}_{1-42}$, total tau and p-tau181 levels, and imagining biomarkers, are now being actively integrated into the designs of AD clinical trials. In terms of therapeutic mechanisms, monitoring these markers may be helpful for go/no-go decision making as well as surrogate markers for disease severity or progression. Furthermore, CSF biomarkers can be used as a tool to enrich patients for clinical trials with prospect of increasing statistical power and reducing costs in drug development. However, the standardization of technical aspects of analysis of these biomarkers is an essential prerequisite to the clinical uses. To accomplish this, global efforts are underway to standardize CSF biomarker measurements and a quality control program supported by the Alzheimer's Association. The current review summarizes therapeutic targets of developing drugs in AD pathophysiology, and provides the most recent advances in the clinical utility of CSF biomarkers and the integration of CSF biomarkers in current clinical trials.

• Proceedings of the Korea Environmental Mutagen Society Conference
• /
• 2004.05a
• /
• pp.101-101
• /
• 2004

• The Journal of Korean Institute of Communications and Information Sciences
• /
• v.26 no.12C
• /
• pp.233-239
• /
• 2001

Among the operations in frequency domain for ADSL G.LITE Modem to perform, FFT and FEQ are most computation-intensive part, of which many researches have been focused on the efficient implementation. Previous papers suggested hardwares suitable for ADSL G.DMT system, which is not feasible for simple G.LITE system. The analysis of frequency domain operations and computational efficiency according to the allocation of hardware resources is performed in this paper. The suggested processor has the structure of one real multiplier and two real adders connected in parallel, which can perform the operations efficiently through the pipeline- and/or parallel-type job scheduling. The suggested processor uses less hardware resources than Kiss\`s ALU structure or FFT/IFFT processor suggested by Wang, so the suggested one is more suitable for G.LITE system than previous works.

• Advances in nano research
• /
• v.10 no.3
• /
• pp.253-261
• /
• 2021

Polydimethylsiloxane (PDMS) is one of the most widely adopted silicon-based organic polymeric elastomers. Elastomeric nanostructures are normally required to accomplish an explicit mechanical role and correspondingly their mechanical properties are crucial to affect device and material performance. Despite its wide application, the mechanical properties of PDMS are yet fully understood. In particular, the time dependent mechanical response of PDMS has not been fully elucidated. Here, utilizing state-of-the-art PeakForce Quantitative Nanomechanical Mapping (PFQNM) together with Force Volume (FV) and Fast Force Volume (FFV), the elastic moduli of PDMS samples were assessed in a time-dependent fashion. Specifically, the acquisition frequency was discretely changed four orders of magnitude from 0.1 Hz up to 2 kHz. Careful calibrations were done. Force data were fitted with a linearized DMT contact mechanics model considering surface adhesion force. Increased Young's modulus was discovered with increasing acquisition frequency. It was measured 878 ± 274 kPa at 0.1 Hz and increased to 4586 ± 758 kPa at 2 kHz. The robust local probing of mechanical measurement as well as unprecedented high-resolution topography imaging open new avenues for quantitative nanomechanical mapping of soft polymers, and can be extended to soft biological systems.